Comparative gene expression profiling of high-grade serous ovarian cancer cells exposed to cisplatin or CX-5461
RNA-seq (gene expression) · human · 60 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Ovarian cancerThis series is part of our curated briefing on it.
- Samples
- 60 samples: 20 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCell death discovery · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE286888_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1210505 and SRA study SRP557223. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 60 samples.
How we read this: 20 replicated groups read from 60 sample titles; they account for 60 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8733288 OV3-VCP-1 OV3-VCP
- GSM8733289 OV3-VCP-2 OV3-VCP
- GSM8733290 OV3-VCP-4 OV3-VCP
- GSM8733291 OV3-CP-1 OV3-CP
- GSM8733292 OV3-CP-2 OV3-CP
- GSM8733293 OV3-CP-4 OV3-CP
- GSM8733294 OV3-VCX-1 OV3-VCX
- GSM8733295 OV3-VCX-2 OV3-VCX
- GSM8733296 OV3-VCX-4 OV3-VCX
- GSM8733297 OV3-CX-1 OV3-CX
- GSM8733298 OV3-CX-2 OV3-CX
- GSM8733299 OV3-CX-4 OV3-CX
- GSM8733300 OVCAR4-VCP-1 OVCAR4-VCP
- GSM8733301 OVCAR4-VCP-2 OVCAR4-VCP
- GSM8733302 OVCAR4-VCP-3 OVCAR4-VCP
- GSM8733303 OVCAR4-CP-1 OVCAR4-CP
- GSM8733304 OVCAR4-CP-2 OVCAR4-CP
- GSM8733305 OVCAR4-CP-3 OVCAR4-CP
- GSM8733306 OVCAR4-VCX-1 OVCAR4-VCX
- GSM8733307 OVCAR4-VCX-2 OVCAR4-VCX
- GSM8733308 OVCAR4-VCX-3 OVCAR4-VCX
- GSM8733309 OVCAR4-CX-1 OVCAR4-CX
- GSM8733310 OVCAR4-CX-2 OVCAR4-CX
- GSM8733311 OVCAR4-CX-3 OVCAR4-CX
- GSM8733312 OV8-VCP-1 OV8-VCP
- GSM8733313 OV8-VCP-3 OV8-VCP
- GSM8733314 OV8-VCP-4 OV8-VCP
- GSM8733315 OV8-CP-1 OV8-CP
- GSM8733316 OV8-CP-3 OV8-CP
- GSM8733317 OV8-CP-4 OV8-CP
- GSM8733318 OV8-VCX-1 OV8-VCX
- GSM8733319 OV8-VCX-3 OV8-VCX
- GSM8733320 OV8-VCX-4 OV8-VCX
- GSM8733321 OV8-CX-1 OV8-CX
- GSM8733322 OV8-CX-3 OV8-CX
- GSM8733323 OV8-CX-4 OV8-CX
- GSM8733324 A14-VCP-1 A14-VCP
- GSM8733325 A14-VCP-2 A14-VCP
- GSM8733326 A14-VCP-3 A14-VCP
- GSM8733327 A14-CP-1 A14-CP
+ 20 more — browse all 60 samples with per-sample file links →
- GSE268514 Integrative genomic analysis of Korean high-grade serous ovarian cancer 161 samples same disease briefing · shares high-grade, ovarian, serous
- GSE154600 Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma 5 samples same disease briefing · shares high-grade, ovarian, serous
- GSE57477 Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes 72 samples same disease briefing · shares ovarian, serous
- GSE311212 Transcriptomic profiling in human ovarian cancer cell line OVCAR-3 following CDK2 inhibitor treatment 6 samples same disease briefing · shares ovarian
- GSE128098 TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target 4 samples same disease briefing · shares ovarian
- GSE314300 Rb CUT&RUN profiling in ovarian cancer cell lines following CDK2 inhibitor treatment 10 samples same disease briefing · shares ovarian
- GSE135242 Hi-C identifies structural variation associated with resistance in paired patient-derived ovarian cancer models 8 samples same disease briefing · shares ovarian
- GSE28330 Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents 107 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.